vidarabine phosphate has been researched along with 6-methylpurine 2'-deoxyriboside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allan, PW; Bennett, LL; Gilbert, KS; Gillespie, GY; King, SA; Montgomery, JA; Parker, WB; Secrist, JA; Sorscher, EJ; Waud, WR; Wells, AH | 1 |
Allan, PW; Hong, JS; Parker, WB; Sorscher, EJ; Waud, WR | 1 |
2 other study(ies) available for vidarabine phosphate and 6-methylpurine 2'-deoxyriboside
Article | Year |
---|---|
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.
Topics: Animals; Antimetabolites, Antineoplastic; Escherichia coli; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Prodrugs; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Retroviridae; Vidarabine Phosphate | 1997 |
Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
Topics: Adenine Phosphoribosyltransferase; Animals; Cell Line, Tumor; Escherichia coli; Genetic Therapy; Genetic Vectors; Humans; Mice; Prodrugs; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Transplantation, Heterologous; Vidarabine Phosphate | 2011 |